betaxolol has been researched along with Cardiovascular Diseases in 4 studies
Cardiovascular Diseases: Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Betaxolol (Kerlon, 8) was found to exhibit an appropriate preclinical pharmacological and human pharmacokinetic profile (elevated oral bioavailability and prolonged plasma half-life) for the treatment of chronic cardiovascular diseases such as hypertension and angina." | 5.27 | Synthesis of a series of compounds related to betaxolol, a new beta 1-adrenoceptor antagonist with a pharmacological and pharmacokinetic profile optimized for the treatment of chronic cardiovascular diseases. ( Binet, JL; Cavero, IG; Lefèvre-Borg, F; Manoury, PM; Rousseau, J, 1987) |
| "Betaxolol appears to be an effective and well tolerated ocular hypotensive agent in a typical glaucoma population, which includes many patients with cardiopulmonary disease." | 2.68 | Betaxolol eye drops. A clinical trial of safety and efficacy. ( Goldberg, H; Goldberg, I, 1995) |
| "Betaxolol (Kerlon, 8) was found to exhibit an appropriate preclinical pharmacological and human pharmacokinetic profile (elevated oral bioavailability and prolonged plasma half-life) for the treatment of chronic cardiovascular diseases such as hypertension and angina." | 1.27 | Synthesis of a series of compounds related to betaxolol, a new beta 1-adrenoceptor antagonist with a pharmacological and pharmacokinetic profile optimized for the treatment of chronic cardiovascular diseases. ( Binet, JL; Cavero, IG; Lefèvre-Borg, F; Manoury, PM; Rousseau, J, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Manoury, PM | 1 |
| Binet, JL | 1 |
| Rousseau, J | 1 |
| Lefèvre-Borg, F | 1 |
| Cavero, IG | 1 |
| Leske, MC | 1 |
| Heijl, A | 1 |
| Hyman, L | 1 |
| Bengtsson, B | 1 |
| Dong, L | 1 |
| Yang, Z | 1 |
| Goldberg, I | 1 |
| Goldberg, H | 1 |
| Yamada, Y | 1 |
| Takayanagi, R | 1 |
| Tsuchiya, K | 1 |
| Ito, K | 1 |
| Ohtani, H | 1 |
| Sawada, Y | 1 |
| Iga, T | 1 |
2 trials available for betaxolol and Cardiovascular Diseases
| Article | Year |
|---|---|
Predictors of long-term progression in the early manifest glaucoma trial.
Topics: Aged; Aged, 80 and over; Antihypertensive Agents; Betaxolol; Blood Pressure; Cardiovascular Diseases | 2007 |
Betaxolol eye drops. A clinical trial of safety and efficacy.
Topics: Aged; Aged, 80 and over; Betaxolol; Cardiovascular Diseases; Drug Tolerance; Female; Glaucoma, Open- | 1995 |
2 other studies available for betaxolol and Cardiovascular Diseases
| Article | Year |
|---|---|
Synthesis of a series of compounds related to betaxolol, a new beta 1-adrenoceptor antagonist with a pharmacological and pharmacokinetic profile optimized for the treatment of chronic cardiovascular diseases.
Topics: Adrenergic beta-Antagonists; Anesthetics, Local; Animals; Antihypertensive Agents; Betaxolol; Biotra | 1987 |
Assessment of systemic adverse reactions induced by ophthalmic beta-adrenergic receptor antagonists.
Topics: Administration, Oral; Administration, Topical; Adrenergic beta-Antagonists; Betaxolol; Cardiovascula | 2001 |